MarketCapTrends
ABVC

ABVC BioPharma Inc. (ABVC)

NASDAQ · Healthcare

ABVC BioPharma Inc. annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • ABVC BioPharma Inc. shareholder equity for the quarter ending December 31, 2025 were 11.1M, a 806.25% increase year-over-year.
  • ABVC BioPharma Inc. shareholder equity for 2025 were 11.1M, a 806.25% increase from 2024.
  • ABVC BioPharma Inc. shareholder equity for 2024 were 1.2M, a 21.10% decrease from 2023.
  • ABVC BioPharma Inc. shareholder equity for 2023 were 1.6M, a 49.84% decrease from 2022.
  • ABVC BioPharma Inc. shareholder equity for 2022 were 3.1M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
ABVC BioPharma Inc. Annual Shareholder Equity (Millions of US $)
2025$11
2024$1
2023$2
2022$3
2021$9
2020$3
2019$-0
2018$-6
2015$0
2013$0
2012$-2
2011$-1
2010$-3
ABVC BioPharma Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$11
2024-12-31$1
2023-12-31$2
2022-12-31$3
2021-12-31$9
2020-12-31$3
2019-12-31$-0
2018-12-31$-6
2015-12-31$0
2015-09-30$1
2013-09-30$0
2012-09-30$-2
2011-09-30$-1
2010-09-30$-3

ABVC BioPharma Inc. Shareholder Equity — FAQ

ABVC BioPharma Inc. (ABVC) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ABVC's shareholder equity history?

The chart and table above show ABVC BioPharma Inc.'s shareholder equity by year and by quarter, including the growth rate.